Generic placeholder image

New Emirates Medical Journal

Editor-in-Chief
ISSN (Online): 0250-6882

Review Article

AI-powered Solutions for Casualty Assessment in Drug Safety and Patient Care

Author(s): Himanshu Sharma, Shushank Mahajan, Nitika Garg, Samrat Chauhan, Monika Saini, Thakur Gurjeet Singh, Sanchit Dhankhar* and Pooja Mittal*

Volume 5, 2024

Published on: 22 August, 2024

Article ID: e02506882313855 Pages: 15

DOI: 10.2174/0102506882313855240809064836

open_access

Open Access Journals Promotions 2
conference banner
Abstract

Objective: An adverse drug reaction is defined as “an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which warrants prevention or specific treatment, alteration of the dosage regimen, or withdrawal of the product, as it predicts hazard from future administration.”

Methodology: Currently used to report such responses, the International Classification of Diseases will soon incorporate WHO's Adverse Reaction Terminology. A medication's bad effects can fall into one of six types, each having its own mnemonic: withdrawal, therapeutic failure, dose-and time-related, non-dose-related, weird, increased withdrawal, and withdrawal overall (time-related). Factors such as timing, illness pattern, investigation findings, and retesting the medicine could be useful in pinpointing the reason for a suspected adverse drug reaction. Management includes treating the effects of the medication specifically as well as, if feasible, stopping it altogether.

Results: Reporting suspected adverse medication reactions is important. Monitoring techniques are able to identify responses and establish connections. There is many software that is used to report and monitor adverse drug reaction responses. Various Pharmacovigilance companies use AI technology to utilize this method to record signals, communicate, and solve new issues in order to limit or avoid harm because of large data size.

Keywords: Adverse drug reaction, Post-marketing surveillance, International adverse drug reaction reporting, AI, Pharmacovigilance, Detection, Assessment.


© 2024 Bentham Science Publishers | Privacy Policy